Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer

Fig. 1

IMPC is associated with poor outcome to adjuvant trastuzumab treatment in HER2-positive breast cancer patients. a Forest plot showing the hazard ratios (HR, squares) and 95% confidence intervals (CI, horizontal lines) of Cox univariate subgroup analysis. b Kaplan–Meier analysis of the probability of DFS of patients who received adjuvant trastuzumab treatment, based on the presence of IMPC. Log rank test was used

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us